APO Research
Talk to an analyst

APO RESEARCH · REPORT

Endoparasiticide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Endoparasiticide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025191 pages

Choose your research edition.

Industry ResearchEndoparasiticide Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Endoparasiticide Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Endoparasiticide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Endoparasiticide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Endoparasiticide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Endoparasiticide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Endoparasiticide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Endoparasiticide include Novartis AG, Merck, Eli Lilly, Bayer AG, Zoetis, Virbac, Vetoquinol, Elanco and Ceva Sante Animlae, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Endoparasiticide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Endoparasiticide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Endoparasiticide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Endoparasiticide market size, projected growth trends, production technologies, key applications, and end-use industries.

Endoparasiticide Segment by Company

Novartis AG

Merck

Eli Lilly

Bayer AG

Zoetis

Virbac

Vetoquinol

Elanco

Ceva Sante Animlae

Boehringer Ingelheim

Endoparasiticide Segment by Type

Ear Tags

Feed Additives

Tablets

Injectables

Endoparasiticide Segment by Application

Veterinary Hospitals or Clinics

Home Care Settings

Animal Farms

Endoparasiticide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endoparasiticide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Endoparasiticide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endoparasiticide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Endoparasiticide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Endoparasiticide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Endoparasiticide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Endoparasiticide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Endoparasiticide Industry Trends Table 2. Endoparasiticide Industry Drivers Table 3. Endoparasiticide Industry Opportunities and Challenges Table 4. Endoparasiticide Industry Restraints Table 5. Global Endoparasiticide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Endoparasiticide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Endoparasiticide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Endoparasiticide Sales Market Share by Manufacturers Table 9. Global Endoparasiticide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Endoparasiticide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Endoparasiticide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Endoparasiticide Manufacturers, Product Type & Application Table 13. Global Endoparasiticide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Endoparasiticide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ear Tags Table 17. Major Manufacturers of Feed Additives Table 18. Major Manufacturers of Tablets Table 19. Major Manufacturers of Injectables Table 20. Global Endoparasiticide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Endoparasiticide Sales by Type (2021-2026) & (K Units) Table 22. Global Endoparasiticide Sales by Type (2027-2032) & (K Units) Table 23. Global Endoparasiticide Sales Market Share by Type (2021-2026) Table 24. Global Endoparasiticide Sales Market Share by Type (2027-2032) Table 25. Global Endoparasiticide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Endoparasiticide Revenue by Type (2021-2026) & (K Units) Table 27. Global Endoparasiticide Revenue by Type (2027-2032) & (K Units) Table 28. Global Endoparasiticide Revenue Market Share by Type (2021-2026) Table 29. Global Endoparasiticide Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Veterinary Hospitals or Clinics Table 31. Major Manufacturers of Home Care Settings Table 32. Major Manufacturers of Animal Farms Table 33. Global Endoparasiticide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Endoparasiticide Sales by Application (2021-2026) & (K Units) Table 35. Global Endoparasiticide Sales by Application (2027-2032) & (K Units) Table 36. Global Endoparasiticide Sales Market Share by Application (2021-2026) Table 37. Global Endoparasiticide Sales Market Share by Application (2027-2032) Table 38. Global Endoparasiticide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Endoparasiticide Revenue by Application (2021-2026) & (K Units) Table 40. Global Endoparasiticide Revenue by Application (2027-2032) & (K Units) Table 41. Global Endoparasiticide Revenue Market Share by Application (2021-2026) Table 42. Global Endoparasiticide Revenue Market Share by Application (2027-2032) Table 43. Global Endoparasiticide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Endoparasiticide Sales by Region (2021-2026) & (K Units) Table 45. Global Endoparasiticide Sales Market Share by Region (2021-2026) Table 46. Global Endoparasiticide Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Endoparasiticide Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 50. North America Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 51. Europe Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 53. Europe Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Endoparasiticide Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Endoparasiticide Sales by Country (2027-2032) & (K Units) Table 60. Global Endoparasiticide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Endoparasiticide Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Endoparasiticide Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Endoparasiticide Revenue Market Share by Region (2021-2026) Table 64. Global Endoparasiticide Revenue Market Share by Region (2027-2032) Table 65. Novartis AG Company Information Table 66. Novartis AG Business Overview Table 67. Novartis AG Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Novartis AG Endoparasiticide Product Portfolio Table 69. Novartis AG Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Merck Endoparasiticide Product Portfolio Table 74. Merck Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eli Lilly Endoparasiticide Product Portfolio Table 79. Eli Lilly Recent Development Table 80. Bayer AG Company Information Table 81. Bayer AG Business Overview Table 82. Bayer AG Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Bayer AG Endoparasiticide Product Portfolio Table 84. Bayer AG Recent Development Table 85. Zoetis Company Information Table 86. Zoetis Business Overview Table 87. Zoetis Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Zoetis Endoparasiticide Product Portfolio Table 89. Zoetis Recent Development Table 90. Virbac Company Information Table 91. Virbac Business Overview Table 92. Virbac Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Virbac Endoparasiticide Product Portfolio Table 94. Virbac Recent Development Table 95. Vetoquinol Company Information Table 96. Vetoquinol Business Overview Table 97. Vetoquinol Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Vetoquinol Endoparasiticide Product Portfolio Table 99. Vetoquinol Recent Development Table 100. Elanco Company Information Table 101. Elanco Business Overview Table 102. Elanco Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Elanco Endoparasiticide Product Portfolio Table 104. Elanco Recent Development Table 105. Ceva Sante Animlae Company Information Table 106. Ceva Sante Animlae Business Overview Table 107. Ceva Sante Animlae Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Ceva Sante Animlae Endoparasiticide Product Portfolio Table 109. Ceva Sante Animlae Recent Development Table 110. Boehringer Ingelheim Company Information Table 111. Boehringer Ingelheim Business Overview Table 112. Boehringer Ingelheim Endoparasiticide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Boehringer Ingelheim Endoparasiticide Product Portfolio Table 114. Boehringer Ingelheim Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Endoparasiticide Distributors List Table 118. Endoparasiticide Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Endoparasiticide Product Image Figure 2. Global Endoparasiticide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Endoparasiticide Market Size (2021-2032) & (US$ Million) Figure 4. Global Endoparasiticide Sales (2021-2032) & (K Units) Figure 5. Global Endoparasiticide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Endoparasiticide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ear Tags Image Figure 9. Feed Additives Image Figure 10. Tablets Image Figure 11. Injectables Image Figure 12. Global Endoparasiticide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Endoparasiticide Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Endoparasiticide Sales Market Share by Type (2021-2032) Figure 15. Global Endoparasiticide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Endoparasiticide Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Endoparasiticide Revenue Market Share by Type (2021-2032) Figure 18. Veterinary Hospitals or Clinics Image Figure 19. Home Care Settings Image Figure 20. Animal Farms Image Figure 21. Global Endoparasiticide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Endoparasiticide Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Endoparasiticide Sales Market Share by Application (2021-2032) Figure 24. Global Endoparasiticide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Endoparasiticide Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Endoparasiticide Revenue Market Share by Application (2021-2032) Figure 27. North America Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Endoparasiticide Sales Market Share by Country (2021-2032) Figure 29. U.S. Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Endoparasiticide Sales Market Share by Country (2021-2032) Figure 34. Germany Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Endoparasiticide Sales Market Share by Country (2021-2032) Figure 41. China Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Endoparasiticide Sales Market Share by Country (2021-2032) Figure 49. Brazil Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Endoparasiticide Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Endoparasiticide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Endoparasiticide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Endoparasiticide Revenue (2021-2032) & (US$ Million) Figure 60. North America Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Endoparasiticide Revenue (2021-2032) & (US$ Million) Figure 62. Europe Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Endoparasiticide Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Endoparasiticide Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Endoparasiticide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Endoparasiticide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ear Tags
  • Feed Additives
  • Tablets
  • Injectables
Applications
  • Veterinary Hospitals or Clinics
  • Home Care Settings
  • Animal Farms
Companies covered
  • Novartis AG
  • Merck
  • Eli Lilly
  • Bayer AG
  • Zoetis
  • Virbac
  • Vetoquinol
  • Elanco
  • Ceva Sante Animlae
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Endoparasiticide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Endoparasiticide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Endoparasiticide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Endoparasiticide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Endoparasiticide Market Dynamics
  1. 2.1 Endoparasiticide Industry Trends
  2. 2.2 Endoparasiticide Industry Drivers
  3. 2.3 Endoparasiticide Industry Opportunities and Challenges
  4. 2.4 Endoparasiticide Industry Restraints
3 Endoparasiticide Market by Manufacturers
  1. 3.1 Global Endoparasiticide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Endoparasiticide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Endoparasiticide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Endoparasiticide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Endoparasiticide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Endoparasiticide Manufacturers, Product Type & Application
  7. 3.7 Global Endoparasiticide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Endoparasiticide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Endoparasiticide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Endoparasiticide Tier 1, Tier 2, and Tier 3
4 Endoparasiticide Market by Type
  1. 4.1 Endoparasiticide Type Introduction
  2. 4.1.1 Ear Tags
  3. 4.1.2 Feed Additives
  4. 4.1.3 Tablets
  5. 4.1.4 Injectables
  6. 4.2 Global Endoparasiticide Sales by Type
  7. 4.2.1 Global Endoparasiticide Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Endoparasiticide Sales by Type (2021-2032)
  9. 4.2.3 Global Endoparasiticide Sales Market Share by Type (2021-2032)
  10. 4.3 Global Endoparasiticide Revenue by Type
  11. 4.3.1 Global Endoparasiticide Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Endoparasiticide Revenue by Type (2021-2032)
  13. 4.3.3 Global Endoparasiticide Revenue Market Share by Type (2021-2032)
5 Endoparasiticide Market by Application
  1. 5.1 Endoparasiticide Application Introduction
  2. 5.1.1 Veterinary Hospitals or Clinics
  3. 5.1.2 Home Care Settings
  4. 5.1.3 Animal Farms
  5. 5.2 Global Endoparasiticide Sales by Application
  6. 5.2.1 Global Endoparasiticide Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Endoparasiticide Sales by Application (2021-2032)
  8. 5.2.3 Global Endoparasiticide Sales Market Share by Application (2021-2032)
  9. 5.3 Global Endoparasiticide Revenue by Application
  10. 5.3.1 Global Endoparasiticide Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Endoparasiticide Revenue by Application (2021-2032)
  12. 5.3.3 Global Endoparasiticide Revenue Market Share by Application (2021-2032)
6 Global Endoparasiticide Sales by Region
  1. 6.1 Global Endoparasiticide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Endoparasiticide Sales by Region (2021-2032)
  3. 6.2.1 Global Endoparasiticide Sales by Region (2021-2026)
  4. 6.2.2 Global Endoparasiticide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Endoparasiticide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Endoparasiticide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Endoparasiticide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Endoparasiticide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Endoparasiticide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Endoparasiticide Revenue by Region
  1. 7.1 Global Endoparasiticide Revenue by Region
  2. 7.1.1 Global Endoparasiticide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Endoparasiticide Revenue by Region (2021-2026)
  4. 7.1.3 Global Endoparasiticide Revenue by Region (2027-2032)
  5. 7.1.4 Global Endoparasiticide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Endoparasiticide Revenue (2021-2032)
  8. 7.2.2 North America Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Endoparasiticide Revenue (2021-2032)
  11. 7.3.2 Europe Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Endoparasiticide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Endoparasiticide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Endoparasiticide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Endoparasiticide Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Endoparasiticide Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Endoparasiticide Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Bayer AG
  20. 8.4.1 Bayer AG Company Information
  21. 8.4.2 Bayer AG Business Overview
  22. 8.4.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer AG Endoparasiticide Product Portfolio
  24. 8.4.5 Bayer AG Recent Developments
  25. 8.5 Zoetis
  26. 8.5.1 Zoetis Company Information
  27. 8.5.2 Zoetis Business Overview
  28. 8.5.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zoetis Endoparasiticide Product Portfolio
  30. 8.5.5 Zoetis Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Endoparasiticide Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Endoparasiticide Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Elanco
  44. 8.8.1 Elanco Company Information
  45. 8.8.2 Elanco Business Overview
  46. 8.8.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Elanco Endoparasiticide Product Portfolio
  48. 8.8.5 Elanco Recent Developments
  49. 8.9 Ceva Sante Animlae
  50. 8.9.1 Ceva Sante Animlae Company Information
  51. 8.9.2 Ceva Sante Animlae Business Overview
  52. 8.9.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Sante Animlae Endoparasiticide Product Portfolio
  54. 8.9.5 Ceva Sante Animlae Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Endoparasiticide Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Endoparasiticide Value Chain Analysis
  2. 9.1.1 Endoparasiticide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Endoparasiticide Production Mode & Process
  6. 9.2 Endoparasiticide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Endoparasiticide Distributors
  9. 9.2.3 Endoparasiticide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst